Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the PandemicResearch Published on 2020-05-212022-10-29 Journal: JAMA Network Open [Category] COVID-19, MERS, SARS, [키워드] acquisition acute respiratory syndrome Analysis asked China circulation clinical Clinical presentations Community conducted coronavirus coronavirus disease coughing COVID-19 COVID-19 pandemic cross-sectional determine diagnosis of COVID-19 disease early phase Fever finding had no HCW HCWs Health care Health care worker hospital hospitals Importance Infection Italy less Local male measure median age Mild MOST Netherland Netherlands objective onset of symptoms Oropharyngeal participant Patient phase Point presentation Prevalence proportion question raising Relevance reported representing respiratory symptom respiratory symptoms Result setting Shortness of breath Spread Symptom tested Travel virus was determined was performed were infected worker [DOI] 10.1001/jamanetworkopen.2020.9673 PMC 바로가기 [Article Type] Research
Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, ItalyArticle Published on 2020-05-202022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] 2019 novel coronavirus 2019-nCoV Admission age analyzed aspartate assist Blood clinical Clinical deterioration consolidation cough COVID-19 D-dimer death deaths defined described Deterioration elevated Factor feature females ground-glass opacity Hospitalized ICU identify imaging intensive care Italy Laboratory laboratory parameter Lactate lombardy management occurred parameter Patient predictor prognostic receive respiratory rate risk SARS-CoV-2 serum severe acute respiratory syndrome coronavirus 2 Standard deviation suggested supportive care survival Symptom transfer [DOI] 10.3390/jcm9051548 PMC 바로가기 [Article Type] Article
Overwhelming COVID-19 Clinical Trials: Call for Prospective Meta-AnalysesCorrespondence Published on 2020-05-202022-10-05 Journal: Trends in pharmacological sciences [Category] SARS, 임상, [키워드] clinical clinical trial COVID-19 Prospective Prospective meta-analysis [DOI] 10.1016/j.tips.2020.05.002 [Article Type] Correspondence
Management of the Clinical and Academic Mission in an Urban Otolaryngology Department During the COVID-19 Global CrisisResearch Articles Published on 2020-05-192022-10-29 Journal: Otolaryngology--Head and Neck Surgery [Category] COVID-19, MERS, SARS, [키워드] airways approach assist Care change clinical COVID-19 COVID-19 crisis COVID-19 pandemic crisis Department directive effort emergence facilitate greater Health majority management Novel coronavirus objective otolaryngology Outpatient pandemic Patient protocol Research Result Safe setting Support telehealth tracheostomy urban was performed [DOI] 10.1177/0194599820929613 PMC 바로가기 [Article Type] Research Articles
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial경증/중등도의 COVID-19 성인 환자에 대한 로피나비르/리토나비르 또는 아르비돌의 효능 및 안전성: 탐색적 무작위 대조 시험Randomized Controlled Trial Published on 2020-05-192022-09-14 Journal: Med (New York, N.Y.) [Category] SARS, 임상, 진단, 치료제, [키워드] adverse event affected antiviral medication approved Arbidol assigned benefit caused Characteristics Chest computed tomography clinical Clinical outcome clinical status clinician comparable Context control group Controlled Controlled trial coronavirus SARS-CoV-2 cough COVID-19 COVID-19 pandemic Deterioration drug effective Efficacy Efficacy and safety enrolled exploratory finding follow-up period funding global pandemic group Guangzhou HIV-1 IMPROVE Influenza Lopinavir/ritonavir Mild moderate Moderate COVID-19 monotherapy no difference novel coronavirus SARS-CoV-2 occurred pathogen Patient patients hospitalized primary endpoint Randomized Randomly receive Respiratory illness responsible Safety SARS-CoV-2 SARS-CoV-2 nucleic acid Scientific community Secondary endpoints Significance standard care supported supportive care tested the disease therapy three group Treatment university virus [DOI] 10.1016/j.medj.2020.04.001 PMC 바로가기 [Article Type] Randomized Controlled Trial
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assayArticle Published on 2020-05-192022-11-01 Journal: Journal of Clinical Virology [Category] COVID-19, MERS, SARS, [키워드] approval assays AusDiagnostics AusDiagnostics assay authorisation clinical Concordance coronavirus COVID-19 demonstrated Diagnosis diagnostic discrepancies Emergency use evaluate implementation MT-PCR multiplex pandemic PCR PCR assay peer-reviewed positive positive sample reference required Result RT-PCR assay SARS-CoV-2 SARS-CoV-2 testing state tested [DOI] 10.1016/j.jcv.2020.104448 PMC 바로가기 [Article Type] Article
Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control studyResearch Paper Published on 2020-05-182022-10-29 Journal: International Journal of Medical Sciences [Category] COVID-19, MERS, SARS, [키워드] acute respiratory distress Admission analyzed BNP Brain breath C-index C-reactive protein cardiac troponin case-control study change Characteristics clinical Clinical data clinical feature Clinical practice Coronavirus disease-19 correlated Course COVID-19 Critical care CRP D-dimer death demonstrated diastolic pressure discharge dynamic dysfunction event Factor feasible hospitalized patient IL-6 independent risk factor Inflammation information Isolation laboratory parameter lactate dehydrogenase LDH Logistic Logistic regression lymphocyte multivariate logistic regression neutrophil outcome parameter Patient PCT peptide predict procalcitonin Prognosis Radiographic Radiography rationale Result Risk factors severe COVID-19 severe COVID-19 patient severe COVID-19 patients significantly SpO2 syndrome two group was collected Wuhan, China [DOI] 10.7150/ijms.46614 PMC 바로가기 [Article Type] Research Paper
Intensive Care Risk Estimation in COVID-19 Pneumonia Based on Clinical and Imaging Parameters: Experiences from the Munich CohortArticle Published on 2020-05-182022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] Accuracy affected C-reactive protein characteristic clinical Clinical parameters collected Computed tomography Confirmed COVID-19 infection coronavirus disease Course COVID-19 CRP diagnostic estimation evaluate evaluated experience Ground glass opacity high risk ICU ICU Patients ICU treatment identify IL-6 imaging Infection intensive care intensive care unit Laboratory leukocyte lung lung parenchyma lymphocyte counts machine multivariate Munich parameter Patient PCR polymerase chain quantified radiological Radiological parameters radiologist random risk sensitivity severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) severe disease course severity significantly significantly increased specificity Standard deviation Treatment Volume was performed [DOI] 10.3390/jcm9051514 PMC 바로가기 [Article Type] Article
Data Monitoring for the Chinese Clinical Trials of Remdesivir in Treating Patients with COVID-19 During the Pandemic CrisisOriginal Research Published on 2020-05-162022-10-29 Journal: Therapeutic innovation & regulatory science [Category] Coronavirus, MERS, SARS, [키워드] anticipated Chinese clinical conducted COVID-19 epidemic COVID-19 pandemic crisis DDM demonstrated double-blind DSMB dynamic eDMC Efficiency hospital ICH information instantaneous investigator Laboratory manuscript monitoring Monitoring clinical trials patients Perspective Placebo provide randomized clinical trial recommendation reliability Remdesivir severe COVID-19 shown Sponsor Standard of care statistical statisticians Study design treating Treatment Trial weakness with COVID-19 Wuhan [DOI] 10.1007/s43441-020-00159-7 PMC 바로가기 [Article Type] Original Research
TAILoR (TelmisArtan and InsuLin Resistance in Human Immunodeficiency Virus [HIV]): An Adaptive-design, Dose-ranging Phase IIb Randomized Trial of Telmisartan for the Reduction of Insulin Resistance in HIV-positive Individuals on Combination Antiretroviral TherapyTAILoR(인간 면역결핍 바이러스[HIV]의 TelmisArtan 및 InsuLin 내성): 복합 항레트로바이러스 요법을 받는 HIV 양성 환자의 인슐린 내성 감소를 위한 Telmisartan의 적응형 설계, 용량 범위 IIb상 무작위 시험Articles and Commentaries Published on 2020-05-152022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] adaptive Analysis antiretroviral drugs Antiretroviral therapy Antiretrovirals ARMS cardiovascular disease check clinical Combination conducted Controlled trial demonstrated Efficacy evaluated fat had no HIV HIV infection homeostasis Human Human immunodeficiency virus identify IIb immunodeficiency virus improvement Improvements index individual Infection insulin insulin resistance Insulin sensitivity interim analysis Intervention investigated ISRCTN liver longitudinal longitudinal analysis measure metabolic abnormalities Metabolic abnormality metabolic disease morbidity and mortality multicenter no difference no differences no significant effect once daily Open-label participant Patient phase plasma Primary outcome primary outcome measure Randomized receiving recruited reduce reduction in Registration resistance Result risk secondary outcome measures significant effect Stage stage II telmisartan Trial with HIV [DOI] 10.1093/cid/ciz589 PMC 바로가기 [Article Type] Articles and Commentaries